Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Driven Gene in Patients with Lung Squamous Cell Carcinoma:  Analysis of Clinicopathologic Characteristics and Prognosis].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 20 Oct 2016

Zhang Tongtong, Li Junling

Abstract excerpt

BACKGROUND: It has been proven that epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and KRAS are common driver genes in non-small cell lung cancer (NSCLC). Molecular targeted therapy increases the overall response rate and progression-free survival (PFS) of patients with EGFR-sensitive mutation or echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase (EML4-ALK)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Cycle Proteins

Share to Microtubule-Associated Proteins

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins p21(ras)

Share to Receptor Protein-Tyrosine Kinases

Share to Serine Endopeptidases

Source

Open in PubMed Open full text

Identifiers

PMID: 27760592
DOI: 10.3779/j.issn.1009-3419.2016.10.02
PMCID: PMC5973419

Genes

EGFR
ALK
EML4
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Driven Gene in Patients with Lung Squamous Cell Carcinoma: Analysis of Clinicopathologic Characteristics and Prognosis].PMID 27760592Read ↗

[Advances of Molecular Targeted Therapy in EGFR-mutated Squamous Cell Lung Cancer].Semantic proximity Read ↗

[Advances on driver oncogenes of non-small cell lung cancer].Semantic proximity Read ↗

[Research progress in non-small cell lung cancer with concomitant EML4-ALK fusion gene and EGFR gene mutation].Semantic proximity Read ↗

[Driver gene mutation and targeted therapy of lung cancer].Semantic proximity Read ↗

Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study.Semantic proximity Read ↗

Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population.Semantic proximity Read ↗

[Detection and Analysis of EGFR and KRAS Mutations in the Patients with Lung Squamous Cell Carcinomas].Semantic proximity Read ↗

[Driver genes and its clinical significance in non-small cell lung cancer].Semantic proximity Read ↗

Molecular oncology of lung cancer.Semantic proximity Read ↗

[Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer].Semantic proximity Read ↗

Clinicopathological characteristics of patients with non-small-cell lung cancer who harbor EML4-ALK fusion gene: a meta-analysis.Semantic proximity Read ↗

EML4‑ALK fusion gene in non‑small cell lung cancer (Review)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.